Tuesday, November 19, 2024

Press Release: Leidos awarded $82M Naval Health Research Center’s (NHRC) Operational Readiness Directorate support IDIQ

“Leidos (NYSE:LDOS), a FORTUNE® 500 science and technology leader, was recently awarded a cost-plus-fixed-fee contract by the Naval Medical Logistics Command. Through this contract, Leidos will continue to perform operational medicine and warfighter performance research for the Naval Health Research Center’s (NHRC) Operational Readiness Directorate. The single award indefinite delivery, indefinite quantity contract holds a maximum value of $82 million. It includes a 60-month period of performance. Work will primarily be performed at NHRC in San Diego, California…”

“Through this contract, Leidos will continue to provide data-driven research modeling to support operational medicine. The modeling is designed to enhance medical decision tools for operational commanders, medical logisticians and field medical personnel. In addition, the Leidos team will continue to analyze warfighter performance with medical research, development, testing, evaluation and surveillance services. The research outcomes are intended to enhance mission readiness, warfighter resilience and rehabilitation strategies for Department of Defense personnel worldwide…” Read the full press release here.

Source: Naval Medical Logistics Command Selects Leidos for Critical Research into Warfighter Operational Readiness – November 23, 2020. Leidos.

Leidos was recently named to the updated list of NXT UP firms poised to make big waves in the Federal sector in 2020 and for years to come.

Related Items

Leidos awarded $82M Naval Health Research Center (NHRC) Operational Readiness Directorate (ORD) IDIQ – FedHealthIT – September 14, 2020

[related-post]

LEAVE A REPLY

Please enter your comment!
Please enter your name here

FedHealthIT Xtra – Find Out More!

Recent News

Don’t Miss A Thing

Jackie Gilbert
Jackie Gilbert
Jackie Gilbert is a Content Analyst for FedHealthIT and Author of 'Anything but COVID-19' on the Daily Take Newsletter for G2Xchange Health and FedCiv.

Subscribe to our mailing list

* indicates required